Molecular markers in colorectal cancer: clinical relevance in stage II colon cancer

Author： Santos Cristina   Vilar Eduardo   Capella Gabriel   Salazar Ramon  

Publisher： Future Medicine

ISSN： 1758-194X

Source： Colorectal Cancer, Vol.2, Iss.3, 2013-06, pp. : 243-263

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular and clinical risk markers in colon cancer trials

By Hill M.J.  

European Journal of Cancer, Vol. 36, Iss. 10, 2000-06 ,pp. : 1288-1291

Elsevier

Access to resources Recommend Favorite

Clinical relevance of molecular markers in lung cancer

By Iyengar P.   Tsao M.-S.  

Surgical Oncology, Vol. 11, Iss. 4, 2002-12 ,pp. : 167-179

Elsevier

Access to resources Recommend Favorite

The Surgeon and Adjuvant Therapy for Stage II Colon Cancer

By Ota David   Nelson Heidi  

Annals of Surgical Oncology, Vol. 14, Iss. 2, 2007-02 ,pp. : 272-273

Springer Publishing Company

Access to resources Recommend Favorite

Molecular markers and the future of colorectal cancer screening

By Carvalho Beatriz   Bosch Linda JW   Van Engeland Manon   Meijer Gerrit A  

Colorectal Cancer, Vol. 2, Iss. 2, 2013-04 ,pp. : 95-97

Future Medicine

Access to resources Recommend Favorite

High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients

By Nielsen Boye  

Clinical and Experimental Metastasis, Vol. 28, Iss. 1, 2011-01 ,pp. : 27-38

Springer Publishing Company

Access to resources Recommend Favorite